Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease

By sjmartinez • February 26, 2025

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick R, Gaine S, Lang I, Chin K, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon LC. Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease. JACC Adv. 2025 Feb 24;4(3):101626. doi: 10.1016/j.jacadv.2025.101626. Epub ahead of print. PMID: 39999520.

Tags: Cardiology/Epi, COMPASS-2, congenital heart disease, GRIPHON, Pooled analysis, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, SERAPHIN

Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression

Chen J, Zhou Q, Su L, Ni L. Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression. Ren Fail. 2025 Dec;47(1):2506812. doi: 10.1080/0886022X.2025.2506812. Epub[...]

Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers

Packard RRS, Pelletier-Galarneau M, Malhotra S, Dorbala S, Chen W, Dilsizian V. Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers. JACC Cardiovasc Imaging. 2025 May 13:S1936-878X(25)00173-1.[...]

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective

Wilkinson MJ, Bijlani P, Davidson MH, Duell PB, Horan M, Malloy MJ, Newfield RS, Pradeep P, Shah PK, Stock EO, Warden BA, Ito MK. Real-World[...]